The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR: Linagliptin

Australian Public Assessment Report

AusPAR

AusPAR: Linagliptin [PDF, 691.74 KB]

AusPAR: Linagliptin [Word, 802.1 KB]

Attachment: Product Information: Linagliptin [PDF, 221.83 KB]

Attachment: Product Information: Linagliptin [Word, 68.22 KB]

Attachment: Extract from Clinical Evaluation Report: Linagliptin [PDF, 943.09 KB]

Attachment: Extract from Clinical Evaluation Report: Linagliptin [Word, 740.19 KB]

Device/Product Name

Trajenta

Active ingredients

Linagliptin

AusPAR Date

26 September 2013

Published

23 October 2013

Submission Number

PM-2012-01168-3-5

Submission Type

Extension of indications

Decision

Approved